Long-Term Assets: The sum of all assets classified as non-current.
Inhibrx Biosciences, Inc. (INBX) had Long-Term Assets of $20.37M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.20M |
|
$1.69B |
|
-- |
|
$0.20M |
|
$331.65M |
|
$-331.45M |
|
$2.02B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$-331.45M |
|
$-329.16M |
|
14.80M |
|
14.98M |
|
$114.01 |
|
$112.62 |
|
| Balance Sheet Financials | |
$160.40M |
|
$6.20M |
|
|
Long-Term Assets |
$20.37M |
$180.77M |
|
$40.73M |
|
-- |
|
$6.45M |
|
$47.18M |
|
$133.58M |
|
$133.58M |
|
$133.58M |
|
14.48M |
|
| Cash Flow Statement Financials | |
$-194.41M |
|
$-2.60M |
|
$71.68M |
|
$277.92M |
|
$152.60M |
|
$-125.33M |
|
$58.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-165724.00% |
|
-165724.00% |
|
-164581.50% |
|
843787.00% |
|
843786.10% |
|
$-197.01M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.48 |
|
766.50 |
|
1263.30% |
|
1263.30% |
|
933.56% |
|
1263.30% |
|
$9.23 |
|
$-13.15 |
|
$-12.97 |
|